Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.1203618 on March 12, 2004

Published online before print March 12, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
jlb.1203618v1
75/6/1016    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, X.
Right arrow Articles by O’Brien, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, X.
Right arrow Articles by O’Brien, E. R.
(Journal of Leukocyte Biology. 2004;75:1016-1021.)
© 2004 by Society for Leukocyte Biology

Antagonism of the {alpha}4 integrin subunit attenuates the acute inflammatory response to stent implantation yet is insufficient to prevent late intimal formation

Xiaoli Ma and Edward R. O’Brien1

Vascular Biology Laboratory, Division of Cardiology, University of Ottawa Heart Institute, Ontario, Canada

1 Correspondence: Vascular Biology Laboratory, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada K1Y4W7. E-mail: eobrien{at}ottawaheart.ca

Mononuclear leukocytes infiltrate the artery wall via integrin-mediated mechanisms and play an integral role in intimal formation after stenting. We sought to determine if acute antagonism of the {alpha}4 subunit of very late antigen-4 is sufficient for the late attenuation of stent intimal area (IA). Twenty-four hypercholesterolemic rabbits underwent iliac artery balloon injury, followed 2 weeks later by stent implantation, and the animals were randomized to receive an anti-{alpha}4 antibody (HP1/2) or a nonspecific isotypic control immunoglobulin (1E6) intravenously 1 h before stenting. Compared with controls, HP1/2-treated rabbits showed 50%, 51%, and 44% reductions in the percentage on intimal cells that were macrophages on days 3, 7, and 28 after stenting and a 59% reduction in intimal proliferation on day 3. Although stent IA was reduced by 63% and 48% in the antibody-treated group compared with the control group on days 3 and 7, this difference was not present on day 28. These data highlight the need for sustained, anti-inflammatory therapies for the prevention of stent intimal formation.

Key Words: restenosis • leukocyte • adhesion




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
C. Deiner, E. Shagdarsuren, P. L. Schwimmbeck, P. Rosenthal, C. Loddenkemper, U. Rauch, M. Pauschinger, R. Dietz, H.-P. Schultheiss, R. Dechend, et al.
Nf-{kappa}b and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation
Cardiovasc Res, July 1, 2007; 75(1): 195 - 204.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
P. Rippstein, M. K. Black, M. Boivin, J. P. Veinot, X. Ma, Y.-X. Chen, P. Human, P. Zilla, and E. R. O'Brien
Comparison of Processing and Sectioning Methodologies for Arteries Containing Metallic Stents
J. Histochem. Cytochem., June 1, 2006; 54(6): 673 - 681.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y.-X. Chen, X. Ma, S. Whitman, and E. R. O'Brien
Novel Antiinflammatory Vascular Benefits of Systemic and Stent-Based Delivery of Ethylisopropylamiloride
Circulation, December 14, 2004; 110(24): 3721 - 3726.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Leukocyte Biology.